BBIO Stock-Based Compensation
Bridgebio Pharma Inc · Stock-Based Compensation
BBIO Stock-Based Compensation
Latest reported$111.95Mperiod ending
BBIO Stock-Based Comp ($1.84M → $111.95M)
Annual stock-based compensation
High-resolution chart · PNG
BBIO stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 133,024,000 | |
| 95,800,000 | |
| 0 | |
| 91,559,000 | |
| 99,505,000 | |
| 58,459,000 | |
| 21,374,000 | |
| 6,067,000 | |
| 1,841,000 |